Literature DB >> 8304756

p53 oncoprotein expression and proliferation index in keratoacanthoma and squamous cell carcinoma.

R L Kerschmann1, T H McCalmont, P E LeBoit.   

Abstract

BACKGROUND AND
DESIGN: Whether solitary keratoacanthoma (KA) is a malignant neoplasm despite its self-limited clinical behavior, and the distinction between KA and squamous cell carcinoma (SCC) are related aspects of a long-standing debate among dermatopathologists. Recent advances toward understanding the molecular basis of malignant transformation may allow this issue to be resolved. Mutant p53 tumor-suppressor protein has been shown to accumulate in cutaneous SCC and other tumors, and may be a relatively specific marker of malignancy. We studied 20SCCs, 20KAs, and an additional 10 regressing KAs (rKA) by immunohistochemistry for the expression of p53 protein. Since p53 is believed to play a pivotal role in the regulation of cell division, we also quantitated proliferation in the tumors by examining Ki-67 antigen expression.
RESULTS: Sixteen (80%) of the KAs showed nuclear staining with anti-p53 antibody, distributed along the outermost layers of the aggregates of neoplastic cells, while 12 (60%) of the SCCs were p53 positive. Eight (80%) of the rKAs also showed p53 positivity. Mean Ki-67 proliferation fraction was higher for KA than for SCC (55% vs 46%), but this difference was not statistically significant. p53 Expression did not correlate with the grade of SCC.
CONCLUSIONS: A majority of KA, rKA, and SCC contain stainable quantities of p53 protein, supporting the view that KA is a type of regressing SCC.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8304756

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  6 in total

1.  Proliferation indexes--a comparison between cutaneous basal and squamous cell carcinomas.

Authors:  M H al-Sader; E Doyle; E W Kay; M Bennett; C B Walsh; B Curran; C Milburn; M Leader
Journal:  J Clin Pathol       Date:  1996-07       Impact factor: 3.411

2.  Are keratoacanthomas variants of squamous cell carcinomas? A comparison of chromosomal aberrations by comparative genomic hybridization.

Authors:  Ole Petter F Clausen; Hans Christian D Aass; Marzieh Beigi; Karin J Purdie; Charlotte M Proby; Victoria L Brown; Morten Mattingsdal; Francesca Micci; Steen Kølvraa; Lars Bolund; Paula M Deangelis
Journal:  J Invest Dermatol       Date:  2006-05-25       Impact factor: 8.551

3.  Angiogenic switch occurs late in squamous cell carcinomas of human skin.

Authors:  S Strieth; W Hartschuh; L Pilz; N E Fusenig
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

4.  Carcinoma-like vascular density in atypic keratoacanthoma suggests malignant progression.

Authors:  S Strieth; W Hartschuh; L Pilz; N E Fusenig
Journal:  Br J Cancer       Date:  2002-11-18       Impact factor: 7.640

5.  Keratoacanthoma and Keratoacanthoma-Like Squamous Cell Carcinoma: Similar Morphology but Different Pathogenesis.

Authors:  Isabela C Watanabe; Renata F Magalhães; Aparecida M de Moraes; Rafael F Stelini; Geórgia F Cintra; Konradin Metze; Maria L Cintra
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

6.  Loss of heterozygosity analysis of keratoacanthoma reveals multiple differences from cutaneous squamous cell carcinoma.

Authors:  A J Waring; M Takata; I Rehman; J L Rees
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.